Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
380 JPY | -1.81% | -5.71% | -18.45% |
Apr. 02 | Roivant Sciences Says Study of Potential Uveitis Treatment Meets Endpoints; Launches Stock Repurchase; Shares Rise | MT |
Apr. 02 | Roivant's anti-inflammatory drug succeeds in mid-stage study | RE |
- Stock Market
- Equities
- 4506 Stock
- News Sumitomo Pharma Co., Ltd.